Early Phase Cancer Immunotherapy
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and...
Saved in:
| Format: | Electronic eBook |
|---|---|
| Language: | English |
| Published: |
Cham :
Springer International Publishing,
2018.
|
| Edition: | 1st ed. 2018. |
| Series: | Current Cancer Research,
|
| Subjects: | |
| ISBN: | 9783319637570 |
| ISSN: | 2199-2584 |
| Online Access: |
|
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 003 | SK-BrCVT | ||
| 005 | 20220618120040.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 171103s2018 gw | s |||| 0|eng d | ||
| 020 | |a 9783319637570 | ||
| 024 | 7 | |a 10.1007/978-3-319-63757-0 |2 doi | |
| 035 | |a CVTIDW08634 | ||
| 040 | |a Springer-Nature |b eng |c CVTISR |e AACR2 | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Early Phase Cancer Immunotherapy |h [electronic resource] / |c edited by Sandip Pravin Patel, Razelle Kurzrock. |
| 250 | |a 1st ed. 2018. | ||
| 260 | 1 | |a Cham : |b Springer International Publishing, |c 2018. | |
| 300 | |a XI, 331 p. 24 illus., 15 illus. in color. |b online resource. | ||
| 490 | 1 | |a Current Cancer Research, |x 2199-2584 | |
| 500 | |a Medicine | ||
| 505 | 0 | |a Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins -- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy -- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies -- Chapter 4 Radiographic Evaluation of Immunotherapy -- Chapter 5 Cellular Therapy -- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation -- Chapter 7 Early Phase Cancer Immunotherapy -- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators -- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials -- Chapter 10 Thoracic Immunotherapy. | |
| 516 | |a text file PDF | ||
| 520 | |a This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy. | ||
| 650 | 0 | |a Cancer research. | |
| 856 | 4 | 0 | |u http://hanproxy.cvtisr.sk/han/cvti-ebook-springer-eisbn-978-3-319-63757-0 |y Vzdialený prístup pre registrovaných používateľov |
| 910 | |b ZE05914 | ||
| 919 | |a 978-3-319-63757-0 | ||
| 974 | |a andrea.lebedova |f Elektronické zdroje | ||
| 992 | |a SUD | ||
| 999 | |c 274341 |d 274341 | ||